Trial intelligence / Profile preview

Dose Exploration of Rotarix in Healthy Infants

NCT00729001Phase 2Completed

Sponsor
GSK
Start
Nov 2000
Primary completion
Sep 2002
Modality
Live Attenuated Vaccines
01

Overview

A Phase 2 trial of rotavirus vaccine, live, oral in rotavirus gastroenteritis, sponsored by GSK. Started Nov 2000; status: completed.

02

Drugs

rotavirus vaccine, live, oral
03

Conditions

rotavirus gastroenteritis

Beyond the preview

Go deeper on NCT00729001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00729001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call